Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Current Taxes (2017 - 2018)

Historic Current Taxes for Corcept Therapeutics (CORT) over the last 2 years, with Q3 2018 value amounting to $1.6 million.

  • Corcept Therapeutics' Current Taxes changed N/A to $1.6 million in Q3 2018 from the same period last year, while for Sep 2018 it was $1.6 million, marking a year-over-year change of. This contributed to the annual value of $66000.0 for FY2017, which is N/A changed from last year.
  • As of Q3 2018, Corcept Therapeutics' Current Taxes stood at $1.6 million.
  • In the past 5 years, Corcept Therapeutics' Current Taxes ranged from a high of $1.6 million in Q3 2018 and a low of $66000.0 during Q4 2017